Batu Biologics Authors Peer-Reviewed Publication

Batu Biologics Authors Peer-Reviewed Publication on Intravenous Vitamin C as Adjuvant to Cancer Immunotherapy
Integration of Holistic Approach to Cancer with Cutting Edge Immunotherapy

Although Batu Biologics is highly focused on the clinical development of ValloVax, a cancer vaccine targeting tumor endothelium, from a corporate perspective we want to ensure that we have the highest possible chance of inducing the most benefit in patients we are treating.

Read the full article at businesswire.com

0